$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Effect of Lorlatinib as first-line treatment for advanced ALK-positive non-small cell lung cancer
2025-10-19 11:44:20
Check Details
How should patients with lung cancer use Xalkori (crizotinib) correctly?
2025-10-19 11:44:20
Check Details
How much will a box of the targeted drug Xalkori (crizotinib) cost after it is included in medical insurance in 2021?
2025-10-19 11:44:20
Check Details
The effect of Xalkori (crizotinib) on patients with brain metastases
2025-10-19 11:44:20
Check Details
How effective is Lorlatinib treatment?
2025-10-19 11:44:20
Check Details
Crizotinib price
2025-10-19 11:44:20
Check Details
Crizotinib capsule price
2025-10-19 11:44:20
Check Details
Has the lung cancer targeted drug Erlotinib (Tarceva) been included in the national medical insurance?
2025-10-19 11:44:20
Check Details
Does Erlotinib Hydrochloride Tablets have any effect on small cell lung cancer?
2025-10-19 11:44:20
Check Details
Efficacy and safety of erlotinib in the treatment of advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
How many years can patients live taking crizotinib
2025-10-19 11:44:20
Check Details
Crizotinib (Xalkori) capsule price
2025-10-19 11:44:20
Check Details
1
2
...
9972
9973
9974
9975
9976
9977
9978
...
10234
10235
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belumosudil for cGVHD: 200mg with Food, Pregnancy Contraception, Liver Monitoring, Drug Interactions
2
Elagolix GnRH Antagonist for Endometriosis Pain: Mechanism, Dosing, Bone and Mood Safety
3
Diazoxide Oral Suspension Inadequate Response: Glucose-Based Titration, Stop at 2–3 Weeks, Re-evaluate Hypoglycemia Cause
4
Ambrisentan Adjunct for IgA Nephropathy Proteinuria: ETA Mechanism, Real-World Evidence, Safety Monitoring
5
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
6
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
7
Lemborexant for Insomnia: Dual Orexin 5/10mg, 7-Hour Bedtime, 7–10-Day Review and Safety
8
Fayuvi (rebisufligene etisparvovec-hopf) for MPS IIIA: AAV9 Single Infusion, Weight-Based Dose, Steroids, Liver/Platelet Monitoring
9
Trelagliptin Once-Weekly DPP-4 for Type 2 Diabetes: Dosing, Renal Adjustment, Discontinuation
10
Orforglipron (Foundayo) vs Metformin: Oral GLP-1 Weight Loss and T2D Use
11
Fayuvi (rebisufligene etisparvovec-hopf/UX111) for MPS IIIA: AAV9 SGSH Gene Therapy, Cognition, and Safety
12
Ramosetron Hydrochloride Orally Disintegrating Tablets: A 5-HT3 Receptor Antagonist for Diarrhea-Predominant IBS